Author: Balzarini, Jan
Title: Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy Cord-id: 43u7afl3 Document date: 2007_1_1
ID: 43u7afl3
Snippet: Several chronic viral infections (such as HIV and hepatitis C virus) are highly prevalent and are a serious health risk. The adaptation of animal viruses to the human host, as recently exemplified by influenza viruses and the severe acute respiratory syndrome coronavirus, is also a continuous threat. There is a high demand, therefore, for new antiviral lead compounds and novel therapeutic concepts. In this Review, an original therapeutic concept for suppressing enveloped viruses is presented tha
Document: Several chronic viral infections (such as HIV and hepatitis C virus) are highly prevalent and are a serious health risk. The adaptation of animal viruses to the human host, as recently exemplified by influenza viruses and the severe acute respiratory syndrome coronavirus, is also a continuous threat. There is a high demand, therefore, for new antiviral lead compounds and novel therapeutic concepts. In this Review, an original therapeutic concept for suppressing enveloped viruses is presented that is based on a specific interaction of carbohydrate-binding agents (CBAs) with the glycans present on viral-envelope glycoproteins. This approach may also be extended to other pathogens, including parasites, bacteria and fungi.
Search related documents:
Co phrase search for related documents- abundant presence and acute respiratory syndrome: 1, 2, 3, 4, 5
- achievable goal and acute respiratory syndrome: 1, 2
Co phrase search for related documents, hyperlinks ordered by date